AzTrials
AzTrials

Sun ExposureEXSPOSOLNCT05316402

Sun Exposure for Outdoor Athletes in Mayotte and Reunion Island

A study testing training on the risks associated with sun exposure and dosimetry in people with Sun Exposure, run by Centre Hospitalier Universitaire de la Réunion at 2 sites in 2 countries.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The UV index in Mayotte and Reunion is greater than 14, eight months out of 12. This index decreases linearly over the period from mid-April to mid-August where it can drop to reach an index of 8 in the month of July. The inhabitants are therefore exposed to a maximum intensity of UV radiation according to the WHO. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Sun Exposure
What is being tested?
training on the risks associated with sun exposure and dosimetry
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
2 sitesin 2 countries
Study dates
Apr 2022to Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Live in Mayotte or Reunion island
  • 18 years old,
  • Practice outdoor sports > 4 hours per week in one of the identified sports associations
  • Belong to the list of targeted associations

Who cannot join

  • Person deprived of liberty by judicial or administrative decision, minor, and person subject to a legal protection measure: guardianship or curators
  • Person not wishing to participate
  • No one speaking any of the following languages: English / French / Shimaore / Kibushi / Creole or Comorian
  • Person who cannot be followed during the 6 months of the study
  • Inability to answer the questionnaire

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

Mayotte1 site
  • Mayotte

    Chirongui

    Lucie AUZANNEAU

    Jessica DUMEZ, MD, MSc

Reunion1 site
  • Reunion

    Saint-Pierre

    Lucie AUZANNEAU

    Antoine BERTOLOTTI, MD, PhD

Other trials in Reunion

About this study

The UV index in Mayotte and Reunion is greater than 14, eight months out of 12. This index decreases linearly over the period from mid-April to mid-August where it can drop to reach an index of 8 in the month of July. The inhabitants are therefore exposed to a maximum intensity of UV radiation according to the WHO.

The World Health Organization (WHO) recommends extreme precautions for indices greater than 11 (avoid exposure between 11 a.m. and 3 p.m. (GMT+3 hours), stay in the shade, wear a t-shirt, sunglasses, hat and sunscreen).

Read more

Sun exposure is a major risk factor in the development of skin cancer, basal cell cancer, squamous cell cancer and cutaneous melanoma. It is also the cause of premature aging of the skin. Moreover, it causes ocular complications such as the occurrence of cataracts and this without distinction of skin phenotype.

There is currently no prevention campaign on the risks of sun exposure in Mayotte or Reunion for adults, while many risky behaviors are observed both in the professional field and during leisure activities. In order to better understand risk-taking and choose appropriate awareness-raising tools, it is necessary to identify the knowledge, attitudes and practices (KAP) of these populations in terms of risk of sun exposure and to measure the impact of solar prevention education actions.

Conditions
Sun Exposure
Being tested
training on the risks associated with sun exposure, dosimetry
Keywords
Sun Exposure, sportsmen

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • training on the risks associated with sun exposureOther

    15-minute power point and presentation on the risks of sun exposure

  • dosimetryOther

    dosimetry

Study groups in NCT05316402
Study groupRoleWhat they receive
training on the risks associated with sun exposureExperimentalpower point on the risks associated with sun exposure
Receives: Other: training on the risks associated with sun exposure; Other: dosimetry

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Improve the knowledge of photo-exposed sportsmen on the risks associated with exposure to the sun

    knowledge quiz

    Measured: 6 month

Secondary outcomes (4)
  1. Assess the change in attitudes and practices of photo-exposed sportsmen

    attitudes and practices of photo-exposed workers quiz

    Measured: 6 month

  2. fitzpatrick scale : classification of skin types (phototype I to VI)

    association between phototype and knowledge level

    Measured: 6 month

  3. knowledge questionnaire on the risks of sun exposure

    association between phototype and knowledge level

    Measured: 6 month

  4. Obtain UV dosimetry data by occupation to confirm risk exposure during working hours.

    dosimetry data

    Measured: 6 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Apr 2022
  2. Study startApr 2022 (estimated)
  3. Primary completionSep 2023 (estimated)
  4. Study completionDec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05316402
Sponsor's protocol ID
2021/CHU/39
Acronym
EXSPOSOL
Status last verified
Feb 2022
First submitted
14 Mar 2022
Last updated
7 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing training on the risks associated with sun exposure and dosimetry in people with Sun Exposure, run by Centre Hospitalier Universitaire de la Réunion at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Mayotte, Reunion. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lucie AUZANNEAU (0262359949 ext. +262, lucie.auzanneau@chu-reunion.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Improve the knowledge of photo-exposed sportsmen on the risks associated with exposure to the sun (time frame: 6 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2022; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in